BNTC compared with EYPT: revenue, margins and what each company keeps, and the suppliers and customers both name

BNTCBenitec Biopharma Inc.

Mkt capRevenueRevenue

EYPTEyePoint, Inc.

Mkt capRevenueRevenue

Compare

BNTCBenitec Biopharma Inc.

EYPTEyePoint, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BNTC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Sep 15 '26±33.9%▼−8.53%×0.25

Q3 FY26±46.8%▲+1.72%×0.04

Feb 12 '26±42.4%▼−2.66%×0.06

Nov 17 '25±33.2%▲+2.81%×0.08

EYPT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 19 '26±69.4%▼−85.28%×1.23

Q2 FY26±51.1%▲+4.97%×0.10

= impliedBNTC realized, solidEYPT realized, hatchedOne scale, both sides: full bar = 86%× = |realized| ÷ impliedSource: market data

May 6 '26

±12.1%

▼−2.91%

×0.24

Q1 FY26±13.6%▼−1.75%×0.13

BNTCBenitec Biopharma Inc.

8.77▼−0.67%· post 8.77

Mkt cap$304.9MRevenue$7,000Q4 FY23Revenue—

EYPTEyePoint, Inc.

0.35▼−8.34%· post 0.34

ClosedOct 30 '26

Mkt cap$30.0MRevenue$507,000Q2 FY26Revenue$31MFY25

Compare

ClosedOct 30 '26

BNTCBenitec Biopharma Inc.

EYPTEyePoint, Inc.

8.77▼−0.67%post 8.77

Price

0.35▼−8.34%post 0.34

$304.9M

Mkt cap

$30.0M

Q4 FY23$7,000

Revenue

$507,000Q2 FY26

—

Revenue

$31MFY25

BNTC8.77▼−0.67%vsEYPT0.35▼−8.34%ClosedOct 30 '26